IC
RPTX

IEQ Capital’s Repare Therapeutics RPTX Stock Holding History

IEQ Capital’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-38,382
Closed -$67.6K – 1984
2025
Q3 		$67.6K Hold
38,382
– – ﹤0.01% 1784
2025
Q2 		$53.4K Hold
38,382
– – ﹤0.01% 1763
2025
Q1 		$37.8K Hold
38,382
– – ﹤0.01% 1566
2024
Q4 		$50.3K Hold
38,382
– – ﹤0.01% 1296
2024
Q3 		$132K Hold
38,382
– – ﹤0.01% 1092
2024
Q2 		$127K Buy
+38,382
New +$137K ﹤0.01% 941

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

IEQ Capital's RPTX Position: Q4 2025 in Review

IEQ Capital sold out of Repare Therapeutics (RPTX) in Q4 2025, closing a stake of 38,382 shares — an estimated $67.6K sold.

IEQ Capital first reported a position in RPTX in Q2 2024 and held it in 6 quarters. The position peaked at $132K in Q3 2024. 46 funds tracked by Wall St. Rank hold RPTX as of Q4 2025.

  • IEQ Capital reported no remaining Repare Therapeutics position as of Q4 2025 after selling out during the quarter.
  • IEQ Capital sold 38,382 Repare Therapeutics shares in Q4 2025, an estimated $67.6K.
  • IEQ Capital first reported a position in Repare Therapeutics in Q2 2024 and held it in 6 quarters.
  • IEQ Capital's Repare Therapeutics position peaked at $132K in Q3 2024.
  • 46 funds tracked by Wall St. Rank held Repare Therapeutics as of Q4 2025.

Based on IEQ Capital's 13F filing for Q4 2025, filed 13 Feb 2026.